ArticlePharmaceutics2022

β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells.

Maedeh Koohi Moftakhari Esfahani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.